You are now leaving GSK Malta Health Portal

You are about to leave a GSK Website. By clicking this link, you will be taken to an external website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on this site. If you do not wish to leave this website, click on “Go Back” below:


Go back

Date of preparation: March 2018

What is the Ellipta?

Ellipta is an easy-to-use inhaler 1that helps your asthma and COPD patients receive the benefit of their medication 2



The Ellipta inhaler - a story of science and innovation

Preparing your Ellipta inhaler 4

The Ellipta requires very little preparation. Once the Ellipta has been removed from its packaging, it is ready for use. There is a dose counter on the front of the Ellipta. When fewer than 10 doses are left, half the dose counter will be red. This is a reminder for the patient to ensure they speak to their healthcare professional before the patient runs out of medicine. After the patient has used their last dose, half the dose counter will be red and the number 0 is displayed – the Ellipta is now empty.

Watch our video on how to prepare the Ellipta

How to use the Ellipta?

Three step administration – patients simply Open, Inhale, Close 4

Step 1: Open
Slide the cover down until you hear a click. The dose counter counts down by one to confirm, and you’re ready to take one dose of your medicine.

Step 2: Inhale
Exhale out. Take a deep, slow breath. Hold your breath for 3-4 seconds.

Step 3: Close
If you want to clean the mouthpiece, use a dry tissue before closing the cover. Slide the cover upwards as far as it will go to cover the mouthpiece.

Watch our video that instructs patients on the three easy steps to use the Ellipta

Video player requires JavaScript enabled. You can download this video here:

Inside the Ellipta

If you’re interested, take a look inside the Ellipta by watching the video below

Video player requires JavaScript enabled. You can download this video here:

See how critical errors with Ellipta compares to other commonly used inhalers in both asthma and COPD:




  1. Svedsater H et al. BMC Pulm Med 2013; 13:72–86.
  2. van der Palen J et al. NPJ Prim Care Respir Med 2016; 26:doi:10.1038/npjpcrm.2016.79.
  3. Grant, AC., Walker, R., et al. The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers. J Aerosol Med Pulm Drug Deliv. 2015. 28(6):474-85.
  4. Anoro Summary of Product Characteristics, GlaxoSmithKline.

Trademarks are owned by or licensed to the GSK group of companies. ©2017 GSK group of companies or its licensor.